D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$773M |
| 2 |
Visa
V
|
+$674M |
| 3 |
HES
Hess
HES
|
+$541M |
| 4 |
Mastercard
MA
|
+$448M |
| 5 |
Oracle
ORCL
|
+$419M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.29B |
| 2 |
Advanced Micro Devices
AMD
|
+$979M |
| 3 |
Citigroup
C
|
+$477M |
| 4 |
Exxon Mobil
XOM
|
+$434M |
| 5 |
Booking.com
BKNG
|
+$355M |
Sector Composition
| 1 | Technology | 27.95% |
| 2 | Consumer Discretionary | 14.18% |
| 3 | Financials | 9.99% |
| 4 | Healthcare | 9.55% |
| 5 | Communication Services | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Resideo Technologies
REZI
$5.39B
| $17.7M | 0.02% |
791,645
-30,843
| -4% | -$692K |
|
552
RxSight
RXST
$410M
| $17.7M | 0.02% |
342,980
+144,410
| +73% | +$7.45M |
|
553
IQVIA
IQV
$31.3B
| $17.6M | 0.02% |
69,744
+67,744
| +3,387% | +$17.1M |
|
554
Builders FirstSource
BLDR
$15.5B
| $17.6M | 0.02% |
84,544
-7,730
| -8% | -$1.61M |
|
555
Novo Nordisk
NVO
$242B
| $17.5M | 0.02% |
136,673
+97,376
| +248% | +$12.5M |
|
556
Carrier Global
CARR
$53.2B
| $17.5M | 0.02% |
301,726
+229,428
| +317% | +$13.3M |
|
557
Prudential Financial
PRU
$37.2B
| $17.4M | 0.01% |
148,242
+65,145
| +78% | +$7.65M |
|
558
Comcast
CMCSA
$124B
| $17.4M | 0.01% |
401,420
+267,172
| +199% | +$11.6M |
|
559
Y-mAbs Therapeutics
YMAB
$390M
| $17.4M | 0.01% |
1,068,159
-255,621
| -19% | -$4.16M |
|
560
Sleep Number
SNBR
$211M
| $17.4M | 0.01% |
1,082,624
-4,341
| -0.4% | -$69.6K |
|
561
SM Energy
SM
$3.14B
| $17.3M | 0.01% |
347,944
-242,140
| -41% | -$12.1M |
|
|
SHYF
562
DELISTED
The Shyft Group
SHYF
| $17.3M | 0.01% |
1,392,964
+64,345
| +5% | +$799K |
|
563
InterDigital
IDCC
$7.7B
| $17.2M | 0.01% |
161,685
-236,739
| -59% | -$25.2M |
|
564
Moog
MOG.A
$6.24B
| $17.1M | 0.01% |
107,138
-19,289
| -15% | -$3.08M |
|
565
CACI
CACI
$10.7B
| $17.1M | 0.01% |
45,011
-5,408
| -11% | -$2.05M |
|
|
ALPN
566
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $17M | 0.01% |
428,555
+133,013
| +45% | +$5.27M |
|
567
Federated Hermes
FHI
$4.1B
| $17M | 0.01% |
469,396
-410,663
| -47% | -$14.8M |
|
568
Thomson Reuters
TRI
$76.8B
| $16.9M | 0.01% |
108,793
-42,292
| -28% | -$6.58M |
|
569
Axos Financial
AX
$5.19B
| $16.9M | 0.01% |
313,414
-32,683
| -9% | -$1.77M |
|
570
Stride
LRN
$6.89B
| $16.9M | 0.01% |
268,378
-221,212
| -45% | -$13.9M |
|
571
Helen of Troy
HELE
$550M
| $16.8M | 0.01% |
146,061
-17,912
| -11% | -$2.06M |
|
572
AppFolio
APPF
$9.92B
| $16.8M | 0.01% |
68,084
+864
| +1% | +$213K |
|
573
Materials Select Sector SPDR Fund
XLB
$5.44B
| $16.7M | 0.01% |
+180,000
| New | +$16.7M |
|
574
SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$10.7B
| $16.7M | 0.01% |
510,900
| – | – |
|
|
NVRO
575
DELISTED
NEVRO CORP.
NVRO
| $16.7M | 0.01% |
1,153,738
-49,246
| -4% | -$711K |
|